136 related articles for article (PubMed ID: 3042129)
1. Paraplatin (carboplatin): new advances in cancer therapy. Update on clinical experiences. Proceedings of a satellite symposium. Madrid, Spain, 2 November 1987.
Cancer Treat Rev; 1988 Jun; 15 Suppl B():1-44. PubMed ID: 3042129
[No Abstract] [Full Text] [Related]
2. Paraplatin (carboplatin). Current status and future prospects. Proceedings of a satellite symposium held at Stockholm, Sweden, 19th June 1985, during the 3rd European Conference on Clinical Oncology.
Cancer Treat Rev; 1985 Sep; 12 Suppl A():1-152. PubMed ID: 3910214
[No Abstract] [Full Text] [Related]
3. Carboplatin (JM-8, CBDCA). A new platinum compound.
Semin Oncol; 1989 Apr; 16(2 Suppl 5):1-48. PubMed ID: 2655092
[No Abstract] [Full Text] [Related]
4. Whither carboplatin? A replacement for or an alternative to cisplatin?
Gil A
J Clin Oncol; 1987 Dec; 5(12):2041-2. PubMed ID: 3316520
[No Abstract] [Full Text] [Related]
5. [Results of a phase-I clinical study of carboplatin--(cyclobutane-1,1-dicarboxylate)diamineplatinum (II)].
Gorbunova VA
Vestn Akad Med Nauk SSSR; 1986; (5):45-7. PubMed ID: 3524054
[No Abstract] [Full Text] [Related]
6. Clinical status of carboplatin.
Canetta R; Franks C; Smaldone L; Bragman K; Rozencweig M
Oncology (Williston Park); 1987 Jul; 1(5):61-70. PubMed ID: 3079484
[TBL] [Abstract][Full Text] [Related]
7. [Organoplatinum compounds. 1987 update].
Extra JM; Espie M; Calvo F; Marty M
Nouv Rev Fr Hematol (1978); 1988; 30(1-2):123-30. PubMed ID: 3290835
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of carboplatin in non-small cell lung cancer.
Olver IN; Donehower RC; Van Echo DA; Ettinger DS; Aisner J
Cancer Treat Rep; 1986 Mar; 70(3):421-2. PubMed ID: 3513947
[No Abstract] [Full Text] [Related]
9. Carboplatin, an active drug in advanced head and neck cancer.
de Andres Basauri L; Lopez Pousa A; Alba E; Sampedro F
Cancer Treat Rep; 1986 Oct; 70(10):1173-6. PubMed ID: 3530443
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of carboplatin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
Booth BW; Weiss RB; Korzun AH; Wood WC; Carey RW; Panasci LC
Cancer Treat Rep; 1985; 69(7-8):919-20. PubMed ID: 3893695
[No Abstract] [Full Text] [Related]
11. Carboplatin for advanced colorectal carcinoma: a phase II study.
Perry DJ; Weiss RB; Creekmore SP; Micetich KC; Curt GA
Cancer Treat Rep; 1986 Feb; 70(2):301-2. PubMed ID: 3512081
[No Abstract] [Full Text] [Related]
12. Phase II study of carboplatin in patients with ovarian carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study.
Eisenhauer EA; Swenerton KD; Sturgeon JF; Fine S; O'Reilly SE
Cancer Treat Rep; 1986 Oct; 70(10):1195-8. PubMed ID: 3530446
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of carboplatin in patients with adenocarcinomas of the upper gastrointestinal tract.
Einzig A; Kelsen DP; Cheng E; Sordillo P; Heelan R; Winn R; Magill G
Cancer Treat Rep; 1985 Dec; 69(12):1453-4. PubMed ID: 3907826
[No Abstract] [Full Text] [Related]
14. Limited activity of carboplatin in malignant lymphoma.
Danieu L; Warrell RP
Cancer Treat Rep; 1986 Jul; 70(7):931-2. PubMed ID: 3521851
[No Abstract] [Full Text] [Related]
15. [Carboplatin--a new platinum cytostatic].
Hejl J; Hejlová N; Mechl Z; Pípalová I; Jurásková V
Cas Lek Cesk; 1985 Jul; 124(29):917-8. PubMed ID: 3899362
[No Abstract] [Full Text] [Related]
16. A phase II study of carboplatin in metastatic transitional cell carcinoma of the bladder (a report of the Medical Research Council Working Party on Urological Cancer, Subgroup in Advanced Bladder Cancer).
Eur J Cancer Clin Oncol; 1987 Apr; 23(4):375-7. PubMed ID: 3301367
[TBL] [Abstract][Full Text] [Related]
17. Cancer chemotherapy: carboplatin v cisplatin.
Drug Ther Bull; 1987 Aug; 25(17):67-8. PubMed ID: 3308394
[No Abstract] [Full Text] [Related]
18. A comparison of the platinum analogues in bladder cancer cell lines.
Powles T; Perry J; Shamash J; Liu W; Oliver T; Joel S
Urol Int; 2007; 79(1):67-72. PubMed ID: 17627172
[TBL] [Abstract][Full Text] [Related]
19. Phase I study of carboplatin (CBDCA) in children with cancer.
Bacha DM; Caparros-Sison B; Allen JA; Walker R; Tan CT
Cancer Treat Rep; 1986 Jul; 70(7):865-9. PubMed ID: 3521846
[TBL] [Abstract][Full Text] [Related]
20. Phase I clinical and pharmacologic trial of carboplatin daily for 5 days.
Van Echo DA; Egorin MJ; Whitacre MY; Olman EA; Aisner J
Cancer Treat Rep; 1984 Sep; 68(9):1103-14. PubMed ID: 6383605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
